Target intelligence / Profile preview

Mitochondrial efficiency

Molecular classification
Other
01

Overview

Mitochondrial efficiency is a physiological metric rather than a single molecular target; it represents the degree of coupling between oxygen consumption and the production of adenosine triphosphate (ATP) during oxidative phosphorylation (PubMed: 21750027). This process is governed by the chemiosmotic gradient across the inner mitochondrial membrane, where a 'proton leak' can dissipate energy as heat instead of driving ATP synthesis, thereby lowering efficiency (PubMed: 8334401). In clinical contexts, diminished mitochondrial efficiency is associated with aging, insulin resistance, and neurodegenerative disorders such as Alzheimer's and Parkinson's disease (PubMed: 16227630). While not a protein or receptor, it is a key therapeutic endpoint for drugs that target specific components like the electron transport chain complexes, sirtuins, or uncoupling proteins (UCPs). Enhancing this efficiency aims to restore cellular energy homeostasis and reduce the production of damaging reactive oxygen species (ROS) (PubMed: 25121481).

Other names
Mitochondrial coupling efficiencyBioenergetic efficiencyP/O ratioRespiratory control ratioMitochondrial respiratory efficiency
02

Mechanism of action

Enhancement of electron transport chain activity, reduction of proton leak through uncoupling protein modulation, or stimulation of mitochondrial biogenesis via PGC-1 alpha activation.

03

Biological functions

Oxidative phosphorylationATP synthesisThermoregulationReactive oxygen species homeostasisMetabolic signaling
04

Disease associations

Type 2 diabetesNeurodegenerative diseaseSarcopeniaCardiovascular diseaseMitochondrial myopathyObesity
05

Safety considerations

Risk of hyperthermia from excessive uncouplingPotential for increased oxidative stress if electron flow is imbalancedLactic acidosisMitotoxicity from off-target inhibition of the electron transport chain
06

Interacting drugs

Metformin

5 more in the full profile.

07

Biomarkers

Oxygen Consumption Rate (OCR)ATP/ADP ratioMitochondrial membrane potential (ΔΨm)Lactate/Pyruvate ratioPhosphocreatine recovery time (via 31P-MRS)

Beyond the preview

Go deeper on Mitochondrial efficiency.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Mitochondrial efficiency.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call